February 23, 2017—Safety-net healthcare providers need a clear strategy and focused action to oppose drug industry efforts to dismantle the 340B drug discount program, two 340B hospital leaders argue in a new peer-reviewed professional journal on leadership, administration, and management in healthcare.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)